Neurol. praxi. 2014;15(3):146-150

CSWS and SIADH associated with CNS disease

MUDr. Ladislav Gurčík, PhD.
Neurologické oddelenie VNsP Levoča

Disorder of water and sodium balance with no obvious associated disease of other internal organs can sometimes be encountered in a patient with a neurological disease. In neurological disease, such disorders result from centrally mediated dysregulation of water and sodium excretion by the kidneys with the development of hypoosmolar hyponatremia. Cerebral salt-wasting syndrome (CSWS) and the syndrome of inappropriate antidiuretic hormone secretion (SIADH) are the most common causes of this disorder. In prognostic terms, it is very important to identify and appropriately treat these two entities. Negative salt balance, hypovolemia, and good therapeutic response to replacement of lost fluid and salt are indicative of the presence of CSWS; by contrast, patients with SIADH are hyper- or euvolemic and restricted fluid intake is the mainstay of therapy.

Keywords: CSWS, SIADH, hypoosmolar hypovolemic hyponatremia, hypoosmolar hypervolemic hyponatremia

Published: June 9, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Gurčík L. CSWS and SIADH associated with CNS disease. Neurol. praxi. 2014;15(3):146-150.
Download citation

References

  1. Adrogué HJ, Madias NE. Hyponatremia: Review. N Engl J Med 2000; 342: 1581-1589. Go to original source... Go to PubMed...
  2. Albanese A. Management of hyponatremia in patients with acute cerebral insults. Archives of Disease in Childhood 2001; 85: 246-251. Go to original source... Go to PubMed...
  3. Ashrafian H, Davey P. A review of the causes of central pontine myelinosis: yet another apoptotic illness? European Journal of Neurology 2001; 8: 103-109. Go to original source... Go to PubMed...
  4. Berendes E, Walter M, Cullen P, Prien T, Van Aken H, Horsthemke J. Secretion of brain natriuretic peptide in patients with aneurysmal subarachnoid haemorrhage. Lancet 1997; 349: 245-149. Go to original source... Go to PubMed...
  5. Casulari LA, Costa KN, Albuquerque R, Naves LA, Suzuki K, Domingues L. Differential diagnosis and treatment of hyponatremia following pituitary surgery. Journal of Neurosurgical Sciences 2004; 48: 11-18. Go to PubMed...
  6. Cole CD, Gottfried ON, Liu JK, Couldwell WT. Hyponatremia in the neurosurgical patient: diagnosis and management. Neurosurgical Focus 2004; 16: 9-22. Go to original source... Go to PubMed...
  7. Ellison DH, Berl T. Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med 2007; 356(20): 2064-2072. Go to original source... Go to PubMed...
  8. Esposito P, Piotti G, Bianzina S, Malul Y, Dal Canton A. The syndrome of inappropriate antidiuresis: pathophysiology, clinical management and new therapeutic options. Nephron Clin Pract 2011; 119: 62-73. Go to original source... Go to PubMed...
  9. Fleming JD, Babu S. Central Pontine Myelinolysis. Images in Clinical Medicine. N Engl J Med 2008; 359: e29. Go to original source... Go to PubMed...
  10. Gross P. Treatment of hyponatremia. Intern Med 2008; 47(10): 885-891. Go to original source... Go to PubMed...
  11. Guerrero R, Pumar A, Soto A, Pomares MA, Palma S, Mangas MA, Leal A, Villamil F. Early hyponatraemia after pituitary surgery: cerebral salt-wasting syndrome. European Journal of Endocrinology 2007; 156: 611-616. Go to original source... Go to PubMed...
  12. Harrigan MR. Cerebral salt wasting syndrome: a review. Neurosurgery 1996; 38: 152-160. Go to original source... Go to PubMed...
  13. Harrigan MR. Cerebral salt wasting syndrome. Crit care clin. 2001; 17: 125-138. Go to original source... Go to PubMed...
  14. Havránek J, Rárová M, Dedek V, Fajt M, Heinige P. Centrální syndrom ztráty soli jako komplikace u pacientky s obstrukčním hydrocefalem. Pediatr pro Praxi, 2008; 9(2): 127-128.
  15. Jiskra J. Hyponatrémie - rizika, příčiny, diagnostika, terapie. I-med 2012: 1-18.
  16. Lath R. Hyponatremia in neurological diseases in ICU. Indian J crit care med 2005; 9(1): 47-51. Go to original source...
  17. Levin ER. Natriuretic peptides. N Engl J Med 1998; 339: 321-328. Go to original source... Go to PubMed...
  18. Palmer BJ. Hyponatremia in patients with central nervous system disease: SIADH versus CSW. Trends in Endocrinology and Metabolism 2003; 14(4): 182-187. Go to original source... Go to PubMed...
  19. Pudil R, Tichý M. Natriuretické peptidy a srdeční selhání - současný pohled. Klin Biochem Metab 2010; 18(39): 190-195.
  20. Rudnay M, Hrabčáková P, Lazúrová I. Hyponatrémia pri syndróme neprimeranej sekrécie vazopresínu (SIADH) - možnosti liečby. Vnitř Lék 2012; 58(1): 52-55. Go to PubMed...
  21. Sherlok M, O'Sullivan E, Agha A, Behan LA, Rawluk D, Brennan P, Tormey W, Thompson CJ. The incidence and pathophysiology of hyponatraemia after subarachnoid haemorrhage. Clinical Endocrinology 2006; 64: 250-254. Go to original source... Go to PubMed...
  22. Vaidya C, Ho W, Freda BJ. Management of hyponatremia: providing treatment and avoiding harm. Cleve Clin J Med 2010; 77: 715-726. Go to original source... Go to PubMed...
  23. Verbalis JG. Management of disorders of water metabolism in patients with pituitary tumors. Pituitary 2002; 5: 119-132. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.